Gastroenterology
Volume 131, Issue 4 , Pages 997-1002, October 2006

Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study

  • Hendrik W. Reesink

      Affiliations

    • Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationAddress requests for reprints to: Hendrik W. Reesink, MD, Department of Gastroenterology and Hepatology, Academic Medical Center, Meibergdreef 9, 1105AZ Amsterdam, The Netherlands. fax: (31) 20 566 9240.
  • ,
  • Stefan Zeuzem

      Affiliations

    • Saarland University Hospital, Homburg, Germany
  • ,
  • Christine J. Weegink

      Affiliations

    • Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
  • ,
  • Nicole Forestier

      Affiliations

    • Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
  • ,
  • Andre van Vliet

      Affiliations

    • Pharma Bio-Research, Zuidlaren, The Netherlands
  • ,
  • Jeroen van de Wetering de Rooij

      Affiliations

    • Pharma Bio-Research, Zuidlaren, The Netherlands
  • ,
  • Lindsay McNair

      Affiliations

    • Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts
  • ,
  • Susan Purdy

      Affiliations

    • Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts
  • ,
  • Robert Kauffman

      Affiliations

    • Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts
  • ,
  • John Alam

      Affiliations

    • Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts
  • ,
  • Peter L.M. Jansen

      Affiliations

    • Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands

Received 10 April 2006; accepted 15 June 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by Vertex Pharmaceuticals Incorporated.

PII: S0016-5085(06)01539-3

doi:10.1053/j.gastro.2006.07.013

Gastroenterology
Volume 131, Issue 4 , Pages 997-1002, October 2006